James M. Russell, MD
- 12Articles
- 36.7KReads1
- 1998–2011Active
- 71Collaborators
- 83Citations2
About
James M. Russell, MD, has published extensively on the treatment of major depressive disorder, generalized anxiety disorder, and bipolar disorder, with a focus on pharmacologic interventions such as duloxetine, sertraline, and imipramine. His work spans clinical trials, meta-analyses, and naturalistic studies addressing treatment-resistant depression, comorbid personality disorders, and the impact of psychiatric conditions on patient care and healthcare utilization. Russell's research also includes investigations into somatoform disorders and the neurological aspects of psychiatric treatment. His publications appeared between 1998 and 2011 in Psychiatrist.com journals.
Publications
Efficacy of Duloxetine on Painful Physical Symptoms in Major Depressive Disorder for Patients With Clinically Significant Painful Physical Symptoms at Baseline: A Meta-Analysis of 11 Double-Blind, Placebo-Controlled Clinical Trials
December 15, 2011
1 Read counts for articles published before 2020 may include some non-human traffic.
2 Citation counts provided by Crossref.
Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.
